| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 11,022,000 | 10,095,000 | 14,724,000 | 11,500,000 | | Cost of Revenue | 8,338,000 | 7,538,000 | 11,101,000 | 8,639,000 | | | Gross Profit | 2,684,000 | 2,557,000 | 3,623,000 | 2,861,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,404,000 | 2,209,000 | 2,499,000 | 2,587,000 | | Non Recurring |
-
| 52,000 | 144,000 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 280,000 | 296,000 | 980,000 | 274,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,000 | 9,000 | 8,000 | (114,000) | | Earnings Before Interest And Taxes | 298,000 | 305,000 | 988,000 | 160,000 | | Interest Expense | 22,000 | 23,000 | 25,000 | 35,000 | | Income Before Tax | 276,000 | 282,000 | 963,000 | 125,000 | | Income Tax Expense | 119,000 | 126,000 | 378,000 | 68,000 | | Minority Interest |
-
|
-
| (17,000) | (11,000) | | | | Net Income From Continuing Ops | 157,000 | 156,000 | 570,000 | 52,000 | | | Non-recurring Events | | Discontinued Operations | 3,000 | (3,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 160,000 | 153,000 | 570,000 | 52,000 | | Preferred Stock And Other Adjustments | (2,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $158,000 | $153,000 | $570,000 | $52,000 |
|
2.03% Nasdaq 0.00%
Income Statement
